KOWA

Specialisation

Cornea

Full title

A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descematorhexis in Patients with Fuchs Endothelial Corneal Dystrophy

Promoter

Kowa Research Institute, Inc

Start date

July 2020

Researchers

Main: Dr José Luis Güell

Co-Researchers: Dr Gris, Dr Barbany

You may be interested in